Canine Leptospirosis: Updated Diagnostic Approaches and Zoonotic Risk Management

Introduction

Canine leptospirosis is a globally prevalent bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. The disease presents a complex diagnostic challenge due to its variable clinical manifestations, the limitations of serological methods, and the need for timely intervention to prevent severe renal and hepatic outcomes. In parallel, the zoonotic potential of Leptospira spp. demands integrated management strategies that bridge veterinary and public health domains. This article provides an exhaustive review of the biological underpinnings of infection, critically evaluates contemporary diagnostic algorithms (with emphasis on PCR versus serology), and outlines evidence-based protocols for zoonotic risk reduction within a One Health framework.

Pathogen Biology and Host Interaction

The genus Leptospira encompasses over 250 pathogenic serovars classified by antigenic composition, with clinically significant serogroups including Canicola, Icterohaemorrhagiae, Grippotyphosa, Pomona, and Australis. These obligate aerobes exhibit a distinctive helical morphology and are motile via periplasmic flagella, enabling penetration through intact mucous membranes or abraded skin [1, 2].

Following entry, Leptospira disseminate hematogenously to target tissues, primarily the proximal renal tubules and hepatic parenchyma. The outer membrane contains lipopolysaccharide (LPS) and several outer membrane proteins (OMPs) such as LipL32, LipL41, and OmpL1, which mediate adhesion to host extracellular matrix components and fibronectin [3, 4]. The host response involves a robust innate immune activation through Toll-like receptor 2 (TLR2) and TLR4 recognition of leptospiral LPS, triggering nuclear factor kappa B (NF-kB) signaling and pro-inflammatory cytokine release [5]. However, pathogenic serovars evade complement-mediated killing by recruiting factor H and C4b-binding protein [6].

The biphasic disease course in dogs includes an acute leptospiremic phase characterized by fever, myalgia, and vasculitis, followed by an immune phase wherein immunoglobulin deposition in renal glomeruli and tubules contributes to tubulointerstitial nephritis [7, 8]. Chronic renal carriage occurs when organisms establish a biofilm-like state within the lumen of proximal tubules, leading to intermittent urinary shedding that perpetuates environmental contamination [9].

Diagnostic Approaches

Serological Methods

The microscopic agglutination test (MAT) remains the reference standard for serovar identification and quantification of agglutinating antibodies [10]. The MAT endpoint is defined as the highest serum dilution at which 50% agglutination of live leptospires is observed. Despite its utility, the MAT has several limitations: it requires live antigen panels representative of local serovars, demonstrates variable sensitivity during the acute phase, and may yield cross-reactions between serogroups [11, 12]. The MAT sensitivity ranges from 50% to 80% during acute illness, increasing to over 90% in convalescent samples [13]. A four-fold rise in titer between paired acute and convalescent samples collected 2 to 4 weeks apart confirms recent infection [14].

Enzyme-linked immunosorbent assays (ELISAs) are widely deployed for initial screening, using antigens such as whole-cell lysates or recombinant LipL32 to detect IgM and IgG [15, 16]. The utility of ELISA is discussed in the context of antigen detection platforms such as those used for feline leukemia virus diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. Commercial ELISA kits demonstrate sensitivity of 85% to 95% and specificity of 90% to 95% compared to MAT, but they do not provide serovar-specific information [17].

Rapid immunochromatographic assays (lateral flow devices) offer point-of-care convenience, using immobilized recombinant antigens (e.g., LipL32) to capture anti-leptospiral antibodies. Their sensitivity is notably lower (60% to 75%) relative to laboratory-based methods, but specificity remains high [18]. These tests are best suited for screening in field settings where laboratory access is limited.

Molecular Diagnostics

Real-time PCR (qPCR) assays target conserved genetic loci such as lipL32, secY, or the 16S rRNA gene, enabling detection of pathogenic Leptospira in blood, urine, cerebrospinal fluid (CSF), and tissue samples [19, 20]. The analytical sensitivity of qPCR for lipL32 is approximately 10 to 50 genome equivalents per reaction [21]. In blood, DNA detection is most reliable during the first 7 days after infection, coinciding with leptospiremia. In urine, shedding begins approximately 7 to 10 days post-infection and can persist for weeks to months [22, 23].

The diagnostic sensitivity of qPCR in urine samples from naturally infected dogs is reported at 90% to 100% during the shedding phase, surpassing MAT in early detection [24]. However, false negatives occur when organisms are present below the limit of detection, when urine pH is highly acidic, or when PCR inhibitors (e.g., urea, hemoglobin, or nitrites) are not removed during nucleic acid extraction [25]. The incorporation of internal amplification controls is essential for monitoring inhibition.

Droplet digital PCR (ddPCR) provides absolute quantification without reliance on standard curves and offers improved tolerance to inhibitors. Preliminary studies indicate ddPCR enhances detection in low-shedding carriers [26].

Culture and Isolation

Definitive diagnosis via culture is rarely performed in routine practice due to the slow growth of Leptospira (up to 16 weeks) and the requirement for specialized Ellinghausen-McCullough-Johnson-Harris (EMJH) medium supplemented with 5-fluorouracil to suppress contaminants [27]. Isolation is valuable for epidemiological surveillance and antibiogram generation but lacks clinical utility due to turnaround time.

Comparative Performance of PCR versus Serology

Table 1 summarizes the diagnostic performance characteristics of qPCR, MAT, and ELISA across the disease timeline.

A diagnostic algorithm incorporating both molecular and serological modalities is recommended for optimal sensitivity and specificity across all stages of disease.

Diagnostic Algorithm and Decision Tree

Figure 1 uses a Mermaid diagram to illustrate a recommended diagnostic workflow. The algorithm prioritizes qPCR during the acute febrile phase and leverages serological tests for retrospective confirmation and epidemiological typing.

flowchart TD
    A[Clinical suspicion: fever, renal/hepatic signs, exposure history], > B{Collect blood and urine}
    B, > C[qPCR from blood]
    B, > D[Urine qPCR]
    B, > E[Serum for MAT and ELISA]
    C, > F{7 days post-onset?}
    D, > G{Days 7-30 post-onset?}
    E, > H[Acute MAT/ELISA]
    F, Yes, > I[Blood qPCR positive: confirm leptospiremia]
    F, No, > J[Repeat blood qPCR in 2-3 days]
    G, Yes, > K[Urine qPCR positive: confirm renal shedding]
    G, No, > L[Repeat urine qPCR weekly for 3 weeks]
    H, > M[Acute titer <1:100]
    H, > N[Acute titer >1:800 or four-fold rise]
    M, > O[Consider another etiology]
    N, > P[Confirm leptospirosis]
    I, > Q[Initiate antibiotic therapy; MAT convalescent in 14 days]
    K, > Q
    P, > R[Urine qPCR to confirm clearance post-treatment]

Zoonotic Risk Management and One Health Implications

Leptospirosis is a prototypical One Health disease, with dogs serving as sentinel hosts and potential amplification reservoirs for human infection [28]. Urine from infected dogs can contaminate water, soil, and food, enabling transmission to humans through cutaneous or mucosal contact. The risk is particularly acute in urban environments with high stray dog populations and inadequate sanitation [29].

Veterinary Infection Control

Veterinary personnel must adhere to standard precautions when handling suspected cases. This includes wearing nitrile gloves, impermeable gowns, and face shields during urine collection, diagnostic sampling, and necropsy. Environmental decontamination with 0.5% sodium hypochlorite, 70% ethanol, or quaternary ammonium compounds is effective against leptospires on non-porous surfaces [30]. Urine-contaminated areas should be disinfected promptly, and personnel should avoid splashing.

Vaccination Strategies

Vaccination with bacterin-based preparations containing the most prevalent serovars (typically Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona) is the cornerstone of preventive management in endemic regions [31]. Vaccination does not confer sterile immunity; breakthrough infections with non-vaccine serovars can occur, and vaccine-induced antibody titers may confound MAT interpretation [32]. Annual booster immunization is recommended for dogs with ongoing exposure risk. The One Health perspective on vaccination is further discussed in the context of related articles on canine leptospirosis diagnosis and vaccination Diagnosis and Management of Canine Leptospirosis: Serovar-Specific Vaccination and One Health Implications.

Environmental Surveillance

Detection of Leptospira DNA in water bodies and soil via quantitative PCR provides a valuable tool for environmental risk assessment. High-risk zones (e.g., kennels, dog parks, urban drainage systems) can be identified and targeted for sanitation interventions [33]. Community-level interventions such as rodent control programs, improved waste management, and restrictions on free-roaming dogs reduce transmission pressure at the human-animal-environment interface [34].

Antibiotic Stewardship

Treatment of canine leptospirosis relies on antimicrobial agents to eliminate the acute infection and prevent chronic shedding. Doxycycline (5 mg/kg PO q12h for 14 days) remains the first-line agent due to its efficacy against both the leptospiremic and renal carriage phases [35]. Penicillins (e.g., ampicillin 20 mg/kg IV q6h) are alternatives during initial hospitalization if vomiting or gastrointestinal dysfunction precludes oral therapy [36]. Judicious use of antibiotics is essential to minimize selection pressure for antimicrobial resistance, which has been documented in Leptospira isolates from both canine and human sources [37].

Emerging Diagnostic Technologies

Metagenomic Next-Generation Sequencing (mNGS)

Shotgun metagenomic sequencing of blood or urine can simultaneously detect Leptospira along with other pathogens in cases of diagnostic uncertainty. The unbiased approach is particularly valuable in immunocompromised patients or in settings where leptospirosis overlaps with other febrile illnesses (e.g., ehrlichiosis, anaplasmosis) [38]. The integration of bioinformatics tools for taxonomic classification and antimicrobial resistance gene detection is discussed in relation to computational models for pathogen surveillance Biological Foundation Models for Veterinary Virology: Predicting Host Tropism and Pathogenicity.

CRISPR-Based Diagnostics

Platforms such as specific high-sensitivity enzymatic reporter unlocking (SHERLOCK) and DNA endonuclease-targeted CRISPR trans reporter (DETECTR) utilize Cas12 or Cas13 enzymes to amplify and detect leptospiral nucleic acids isothermally. These systems achieve attomolar-level sensitivity and can yield results in under one hour without thermocyclers [39]. Ongoing development aims to deploy these platforms as field-deployable diagnostics for low-resource settings.

Proteomic and Metabolomic Biomarkers

Mass spectrometry-based approaches are under investigation to identify host-derived biomarkers of acute leptospirosis. Candidate peptides, including acute-phase proteins and lipid mediators, may differentiate leptospirosis from other febrile illnesses and stratify disease severity [40]. Multiplexed assays integrating these markers with direct pathogen detection could transform diagnostic accuracy.

Comparative Epidemiology: Dogs as Sentinels

Canine leptospirosis epidemiology often mirrors human disease patterns within the same geographic region. Seroprevalence surveys in dogs provide early warning signals for emerging serovars and shifts in transmission ecology [41]. For example, the increasing identification of Australis serogroup in both canine and human cases in Europe suggests a common exposure pathway, likely involving brown rats (Rattus norvegicus) and contaminated surface water [42, 43]. Integrating canine serosurveillance into public health monitoring systems strengthens early outbreak detection.

Conclusion

Canine leptospirosis remains a diagnostically challenging and zoonotically significant disease. Contemporary diagnostics should employ a dual approach: qPCR for acute and shedding-phase detection and MAT with paired sera for serovar-level confirmation and epidemiological tracking. One Health management requires coordinated action among veterinarians, public health authorities, and environmental managers to interrupt transmission at the animal-human interface. Vaccination, infection control, environmental monitoring, and antimicrobial stewardship form a comprehensive framework for reducing disease burden across species. Continued advances in molecular and point-of-care technologies promise to further enhance diagnostic accuracy and expand access to reliable testing in resource-limited settings.

References

[1] Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2006;118(3-4):219-226.

[2] Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5(9):1413-1425.

[3] Hauk P, Macedo F, Romero EC, et al. In LipL32, the major leptospiral lipoprotein, the C-terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin. Infect Immun. 2008;76(6):2642-2650.

[4] Cullen PA, Haake DA, Adler B. Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev. 2004;28(3):291-318.

[5] Nahori MA, Fournier E, Haro J, et al. Involvement of Toll-like receptors in the recognition of leptospiral glycolipids. J Immunol. 2005;175(10):6882-6892.

[6] Meri T, Murgia R, Stefanel P, et al. Regulation of complement activation at the C3 level by serum resistant leptospires. Microb Pathog. 2005;39(3):97-105.

[7] Sykes JE, Hartmann K, Lunn KF, et al. 2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med. 2011;25(1):1-13.

[8] Schreiber P, Martin V, Thibault JC, et al. Canine leptospirosis: clinical and serological features of 61 cases. J Vet Intern Med. 2005;19(5):711-715.

[9] Ristow P, Bourhy P, da Cruz McBride FW, et al. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog. 2007;3(7):e97.

[10] Musso D, La Scola B. Laboratory diagnosis of leptospirosis: a challenge. J Microbiol Immunol Infect. 2013;46(4):245-252.

[11] Levett PN, Branch SL, Whittington CU, et al. Two methods for rapid serological diagnosis of acute leptospirosis. Clin Diagn Lab Immunol. 2001;8(2):349-351.

[12] Goris MG, Boer KR, Duarte T, et al. Prospective evaluation of three rapid diagnostic tests for diagnosis of human leptospirosis. PLoS Negl Trop Dis. 2013;7(7):e2290.

[13] Cumberland PC, Everard CO, Prevost AM. A comparison of the sensitivity of the IgM ELISA with the MAT for the diagnosis of leptospirosis. Trans R Soc Trop Med Hyg. 1996;90(3):279-281.

[14] Brown K, Prescott J, McBride A. Laboratory diagnosis of leptospirosis in dogs: a review. J Small Anim Pract. 2020;61(12):727-736.

[15] Flannery B, Costa F, Carvalho MS, et al. Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the diagnosis of leptospirosis. Am J Trop Med Hyg. 2001;64(1-2):89-93.

[16] Senthilkumar K, Subathra M, Nagalingam M, et al. Recombinant LipL32 antigen-based IgM ELISA for serodiagnosis of canine leptospirosis. Vet World. 2021;14(6):1534-1540.

[17] Prescott JF, McDonough PL. Canine leptospirosis: the role of vaccination in prevention. Vet Clin North Am Small Anim Pract. 2010;40(6):1151-1161.

[18] Marroquin SE, Jones ML, Kusalik AJ, et al. Evaluation of a lateral flow immunochromatographic assay for detection of antibodies to Leptospira in dogs. J Vet Diagn Invest. 2019;31(5):740-744.

[19] Merien F, Baranton G, Perolat P. Comparison of polymerase chain reaction with microagglutination test and culture for diagnosis of leptospirosis. J Infect Dis. 1995;172(1):281-285.

[20] Ahmed A, Engelberts MFM, Boer KR, et al. Development and validation of a real-time PCR for detection of pathogenic Leptospira species in clinical samples. PLoS One. 2009;4(10):e7428.

[21] Stoddard RA, Gee JE, Wilkins PP, et al. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn Microbiol Infect Dis. 2009;64(3):247-255.

[22] Groom J, Broughton ES, Casey M, et al. Quantitative real-time PCR for detection of Leptospira in the urine of dogs. J Vet Diagn Invest. 2008;20(4):484-487.

[23] Winzelberg S, Tasse S, Baker R, et al. Detection of Leptospira DNA in urine of dogs using a validated qPCR assay. J Vet Intern Med. 2017;31(4):1184-1191.

[24] Lizer J, Velineni S, Nally JE. Comparison of serological and molecular assays for the diagnosis of acute canine leptospirosis. J Vet Intern Med. 2014;28(5):1486-1491.

[25] Reitstetter RE. Development of a quantitative real-time PCR assay for detection of Leptospira interrogans serovar Hardjo. J Vet Diagn Invest. 2006;18(6):579-583.

[26] Corrêa JZ, Vasconcelos HA, Marques MR, et al. Droplet digital PCR for detection of Leptospira interrogans in urine samples. PLoS Negl Trop Dis. 2021;15(8):e0009675.

[27] Faine S, Adler B, Bolin C, et al. Leptospira and Leptospirosis. 2nd ed. MedSci Press; 1999.

[28] Rabinowitz PM, Gordon Z, Chudnov DM. Animals as sentinels of human environmental health hazards: an evidence-based analysis. Ecohealth. 2005;2(3):248-259.

[29] Gsell AS, Ross MA, Vinetz JM. A One Health approach to leptospirosis in urban slums. Ecohealth. 2021;18(1):45-57.

[30] Goudie AJ, Innes JA, Grundy DA. Disinfection of leptospires on surfaces. J Hyg (Lond). 1986;96(3):511-516.

[31] Morgan AP, Ellis WA. The efficacy of a Leptospira interrogans serovar Canicola and Icterohaemorrhagiae vaccine against challenge with Leptospira kirschneri serovar Grippotyphosa in dogs. Vet Rec. 2007;160(18):624-628.

[32] Fettelschoss-Gabriel A, Krupka I, Willi B, et al. Interference of vaccination against Leptospira with serological diagnosis: a review. Vet J. 2016;215:102-108.

[33] Benacer D, Thong KL, Wan Hafiz WI, et al. Environmental surveillance of Leptospira in water and soil using qPCR. Environ Microbiol. 2013;15(10):2751-2760.

[34] Costa F, Hagan JE, Calcagno J, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis. 2015;9(9):e0003898.

[35] Greene CE, Sykes JE. Leptospirosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012:431-448.

[36] Alt DP, Zuerner RL, Bolin CA. Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar Hardjo. J Am Vet Med Assoc. 2001;219(5):636-639.

[37] Miotto BA, Faria MT, Ribeiro DA, et al. Antimicrobial susceptibility of Leptospira spp. isolated from dogs in Brazil. J Med Microbiol. 2018;67(9):1297-1304.

[38] Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370(25):2408-2417.

[39] Gootenberg JS, Abudayyeh OO, Lee JW, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017;356(6336):438-442.

[40] Sivasankari S, Ramachandran S, Bhat S, et al. Proteomic profiling of serum samples from canine leptospirosis patients reveals potential diagnostic markers. J Proteomics. 2019;200:48-57.

[41] Haake DA, Levett PN. Lept